Rachel lenington athira
WebAug 16, 2024 · Athira made further leadership changes following the the recent death of board chair Tadataka Yamada. ... New Athira execs Mark Worthington, general counsel, … WebApr 26, 2024 · Rachel Lenington, M.B.A., Chief Operating Officer, has more than 20 years of strategic and operational leadership experience in drug development, commercialization and launch. ... Athira has the right board to oversee the company and a …
Rachel lenington athira
Did you know?
WebRachel Lenington is Chief Operating Officer at Athira Pharma Inc. See Rachel Lenington's compensation, career history, education, & memberships. WebApr 3, 2024 · Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. ... Rachel Lenington MBA. Chief Operating Officer. George W Bickerstaff III ...
WebWork Biography for Rachel Lenington, Athira Pharma. Rachel Lenington works as a Chief Technology Officer & Head of Product Development Strategy at Athira Pharma, which is a Chemicals & Related Products company with an estimated 20 employees; and founded in … WebCurrently, Rachel Lenington occupies the position of Chief Operating Officer at Athira Pharma, Inc. Ms. Lenington previously occupied the position of Director & Manager-Global …
WebJun 14, 2024 · Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, … WebJun 22, 2024 · Athira Pharma announces Rachel Lenington as the Chief Technology Officer, Head of Product Development Strategy. FREMONT, CA: Athira Pharma, Inc., a late clinical-stage biopharmaceutical firm dedicated to developing small molecules to restore neuronal health and prevent neurodegeneration, has announced Rachel Lenington as the Chief …
WebJun 14, 2024 · Ms. Lenington added, “I am delighted to join Athira’s dedicated efforts to discover and develop innovative therapies for neurodegeneration, with the ultimate goal of helping patients ...
WebBOTHELL, Wash., June 14, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing goat mcdonoughWebJun 15, 2024 · June 15, 2024. Rachel Lenington. BOTHELL, Wash., June 14, 2024 (GLOBE NEWSWIRE) — Athira Pharma a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the appointment of Rachel Lenington as Chief Technology Officer, Head of … goat mating processWebRachel Lenington. Chief Operating Officer. Rachel brings extensive strategic and operational leadership experience in drug development, commercialization and launch to Athira. … g.o.a.t meaningWebRachel Lenington. Via Email . Re: Offer Letter. Dear Rachel: I am pleased to offer you a position with Athira Pharma, Inc. (the “Company”) in accordance with the terms of this offer letter (the “Agreement”). 1.Title; Position. You will serve as the Company’s Chief Technology Officer and Head of Product Development Strategy. goat meadow snow playWebNovember 10, 2024. Athira Pharma Reports Third Quarter 2024 Financial Results and Business Update. Completed enrollment of ACT-AD trial with topline data expected in the first half of 2024; LIFT-AD is actively recruiting with topline data expected by the end of 2024 – – Presented program updates and baseline data from ATH-1017’s ongoing Phase 2 and … bone graft for bone loss in jawWebJun 22, 2024 · Athira Pharma announces Rachel Lenington as the Chief Technology Officer, Head of Product Development Strategy. FREMONT, CA: Athira Pharma, Inc., a late clinical … goat meaningbone graft healing time